BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Federal Trade Commission
Colorcon
McKinsey
Queensland Health
Cantor Fitzgerald
Julphar
Medtronic
Merck

Generated: January 16, 2018

DrugPatentWatch Database Preview

PROTRIPTYLINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Protriptyline Hydrochloride patents expire, and what generic alternatives are available?

Protriptyline Hydrochloride is a drug marketed by Epic Pharma Llc, Sigmapharm Labs Llc, and West-ward Pharms Int. and is included in three NDAs.

The generic ingredient in PROTRIPTYLINE HYDROCHLORIDE is protriptyline hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the protriptyline hydrochloride profile page.
Drug patent expirations by year for PROTRIPTYLINE HYDROCHLORIDE
Pharmacology for PROTRIPTYLINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for PROTRIPTYLINE HYDROCHLORIDE

US Patents and Regulatory Information for PROTRIPTYLINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Epic Pharma Llc PROTRIPTYLINE HYDROCHLORIDE protriptyline hydrochloride TABLET;ORAL 202220-001 Nov 19, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sigmapharm Labs Llc PROTRIPTYLINE HYDROCHLORIDE protriptyline hydrochloride TABLET;ORAL 090462-002 May 3, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Epic Pharma Llc PROTRIPTYLINE HYDROCHLORIDE protriptyline hydrochloride TABLET;ORAL 202220-002 Nov 19, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sigmapharm Labs Llc PROTRIPTYLINE HYDROCHLORIDE protriptyline hydrochloride TABLET;ORAL 090462-001 May 3, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int PROTRIPTYLINE HYDROCHLORIDE protriptyline hydrochloride TABLET;ORAL 078913-002 Sep 16, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int PROTRIPTYLINE HYDROCHLORIDE protriptyline hydrochloride TABLET;ORAL 078913-001 Sep 16, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Cantor Fitzgerald
Farmers Insurance
Johnson and Johnson
Cipla
Dow
McKinsey
Colorcon
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot